Evidence map›Paper›PMID 41986874›Full record

ArticleImmunoHorizons2026

Presentation of the protective epitope in a Chlamydia muridarum MOMP vaccine is dependent on γ-interferon-inducible lysosomal thiol reductase (GILT).

Sukumar Pal, Raymond M Johnson, Delia F Tifrea, Peter Cresswell, Luis M de la Maza

Abstract read
In one paragraph

Article in ImmunoHorizons, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sukumar PalDepartment of Pathology and Laboratory Medicine, University of California, Irvine, Irvine, CA, United States.ORCID 0000-0001-5170-5121
Raymond M JohnsonDepartment of Internal Medicine, Yale University School of Medicine, New Haven, CT, United States.
Delia F TifreaDepartment of Pathology and Laboratory Medicine, University of California, Irvine, Irvine, CA, United States.
Peter CresswellDepartments of Immunobiology and Cell Biology, Yale University School of Medicine, New Haven, CT, United States.
Luis M de la MazaDepartment of Pathology and Laboratory Medicine, University of California, Irvine, Irvine, CA, United States.

Funding

Recombinant C. trachomatis vaccineR01AI067888 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI DE LA MAZA, LUIS M · 2007 to 2011
$1.9M
Trapping membrane proteins with adjuvant-carrying amphipols for vaccine formulatiR01AI092129 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI COCCO, MELANIE J, DE LA MAZA, LUIS M · 2011 to 2014
$1.3M
NIAID NIH HHS R01 AI067888NIAID NIH HHS R01 AI092129
6 · The paper itself

Abstract

The Chlamydia outer membrane complex has approximately 20 cysteine-rich proteins, including the major outer membrane protein (MOMP) with 8 cysteines. The enzyme γ-interferon-inducible lysosomal thiol reductase (GILT) is expressed constitutively in lysosomes of antigen presenting cells and reproductive tract epithelial cells. GILT catalyzes disulfide bond reduction during protein degradation that generates T cell epitopes. To evaluate the role that GILT plays in chlamydial infections, C57BL/6 WT mice and mice deficient in Ifi30 (GILT-KO) were challenged vaginally with Chlamydia muridarum (Cm). Both were equally susceptible to the Cm infection and upper genital tract pathology. To assess GILT's role in processing MOMP epitopes, WT and GILT-KO mice were immunized with native (nMOMP) or recombinant (rMOMP) antigens. In both strains vaccination with Cm nMOMP and rMOMP induced a similar spectrum of MOMP-specific antibodies. nMOMP immunization generated higher neutralizing antibody titers than rMOMP, but neutralizing titers did not differ between mouse strains. Splenocytes from vaccinated WT and GILT-KO mice recognized T cell epitopes in nMOMP, and to a lesser extent with rMOMP. No protection was seen in either WT or GILT-KO mice vaccinated with rMOMP based on intensity and duration of vaginal shedding, upper genital tract pathology, and fertility post-infection. nMOMP vaccination protected WT mice based on attenuated bacterial shedding and preserved fertility but nMOMP-vaccinated GILT-KO mice were not protected. The failure of nMOMP vaccination in GILT-KO mice revealed that GILT-dependent MOMP epitope processing was outcome determinative and identified a pan-serovar, likely protective, class II T cell epitope in MOMP constant domain 3.

Indexed as

Bacterial Outer Membrane ProteinsBacterial VaccinesChlamydia InfectionsChlamydia muridarumOxidoreductases Acting on Sulfur Group DonorsAnimalsAntibodies, BacterialAntibodies, NeutralizingAntigen PresentationEpitopes, T-LymphocyteFemaleMiceMice, Inbred C57BLMice, KnockoutProtein Subunit VaccinesAntibodies, BacterialAntibodies, NeutralizingBacterial Outer Membrane ProteinsBacterial VaccinesEpitopes, T-LymphocyteIfi30 protein, mouseOxidoreductases Acting on Sulfur Group DonorsProtein Subunit VaccinesChlamydia vaccineGILT antigen processing and presentationmouse modelnMOMP and rMOMP protective epitope

Identifiers

PMID41986874
PMCPMC13082905

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.